Generation Bio's market cap is currently $38.80M. The company's EPS TTM is $-3.12; its P/E ratio is ―; Generation Bio is scheduled to report earnings on August 12, 2025, and the estimated EPS forecast is $-3.15. See an overview of income statement, balance sheet, and cash flow financials.
